🇺🇸 FDA
Patent

US 9758529

Fused dihydro-4H-pyrazolo[5,1-C][1,4]oxazinyl compounds and analogs for treating CNS disorders

granted A61PA61P25/00A61P25/04

Quick answer

US patent 9758529 (Fused dihydro-4H-pyrazolo[5,1-C][1,4]oxazinyl compounds and analogs for treating CNS disorders) held by PGI Drug Discovery LLC expires Mon Sep 07 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
PGI Drug Discovery LLC
Grant date
Tue Sep 12 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 07 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
54
CPC classes
A61P, A61P25/00, A61P25/04, A61P25/18, A61P25/22